MAM
MRNA icon

Morse Asset Management’s Moderna MRNA Stock Holding History

Morse Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,317
Closed -$663K – 148
2023
Q1 		$663K Buy
+4,317
New +$712K 0.22% 97
2021
Q4 		– Sell
-6,667
Closed -$2.57M – 179
2021
Q3 		$2.57M Buy
6,667
+87
+1% +$32.1K 0.61% 46
2021
Q2 		$1.55M Buy
6,580
+3,580
+119% +$640K 0.37% 68
2021
Q1 		$393K Buy
+3,000
New +$435K 0.1% 124

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morse Asset Management's MRNA Position: Q2 2023 in Review

Morse Asset Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 4,317 shares — an estimated $663K sold.

Morse Asset Management first reported a position in MRNA in Q1 2021 and held it in 4 quarters. The position peaked at $2.57M in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Morse Asset Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Morse Asset Management sold 4,317 Moderna shares in Q2 2023, an estimated $663K.
  • Morse Asset Management first reported a position in Moderna in Q1 2021 and held it in 4 quarters.
  • Morse Asset Management's Moderna position peaked at $2.57M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Morse Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.